science1 publisher
Biopharma leaders told McKinsey they will buy more outsourced manufacturing at higher prices
A survey of more than 300 executives has a majority planning to lean harder on contract manufacturers even as batch prices climb. McKinsey reports rising cost sensitivity and thin supplier loyalty among the same buyers.
Publishers:genengnews.com
Reality
- Evidence55
- Adoption68
- Hype gap+18
- Incentives72
- Confidence52